Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.
about
Exosomes genetic cargo in lung cancer: a truly Pandora's boxOncogenomic disruptions in arsenic-induced carcinogenesis.Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.Emergence of miR-34a in radiation therapy.Extracellular miRNAs as biomarkers in cancer.Identification of metastasis-associated microRNAs in serum from rectal cancer patients.Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3.MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.Prognostic Circulating MicroRNA Biomarkers in Early-Stage Non-Small Cell Lung Cancer: A Role for miR-150.Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies.Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals.Serum microRNAs - potent biomarkers for radiation biodosimetry.
P2860
Q28079149-436E7973-F6D6-4E28-B39D-4DDC379BC72FQ33649020-4EFC7B5B-B676-447C-A84D-2D8808D04B0FQ37662007-8F4EB475-ED14-4762-8E49-8FE983BE8846Q37706539-C0155C6F-6C55-45CE-9C90-ADAD7532D811Q38724657-E63BBEB3-3142-4269-A67F-459C79B7259BQ38867417-8FD1F393-88CF-4332-8156-6EE64F5A57F2Q44449817-AF77AA3D-2BE7-47F0-BC17-452A9BB87B5EQ45944325-6B9E84DB-2AFB-4713-A294-1050003585EEQ46304048-5FE5D203-E1C7-46A0-9D1A-8BE22E8B3A63Q47663124-17D4E3CA-B96C-4C34-94DC-419660170D14Q49503724-A3ED6739-FE27-4B01-A24A-3C23EC1C8B8FQ53489250-2ADA99DC-D53D-4010-8DFC-8BB8A99F5BC2Q55108859-61FBB806-8956-44A1-ABE7-FEB53CDBACBEQ55283958-81361EA1-A39D-4CBA-8ABF-43BC93B1C276
P2860
Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Circulating miR-29a and miR-15 ...... or non-small cell lung cancer.
@en
type
label
Circulating miR-29a and miR-15 ...... or non-small cell lung cancer.
@en
prefLabel
Circulating miR-29a and miR-15 ...... or non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Circulating miR-29a and miR-15 ...... for non-small cell lung cancer
@en
P2093
Alan D D'Andrea
Colin O'Leary
David Kozono
Dipanjan Chowdhury
Justyna Chałubińska-Fendler
Peter V Deraska
Sanket S Acharya
Wojciech Fendler
P2860
P2888
P356
10.1186/S13014-016-0636-4
P577
2016-04-27T00:00:00Z
P6179
1002517932